RMC6291
- Product Name
- RMC6291
- CAS No.
- 2641998-63-0
- Chemical Name
- RMC6291
- Synonyms
- RMC6291;elironrasib;RMC6291/ Elironrasib;Elironrasib (RMC-6291);2-(1-{1-[4-(dimethylamino)-4-methylpent-2-ynoyl]-4-fluoropiperidin-4-yl}-N-methylformamido)-N-{22-ethyl-21-[2-(1-methoxyethyl)pyridin-3-yl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetraazapentacyclo[18.5.2.12,?.11?,1?.023,2?]nonacosa-1(25),20,23,26-tetraen-8-yl}-3-methylbutanamide_chiral;(3S)-N1-[N-[[1-[4-(Dimethylamino)-4-methyl-1-oxo-2-pentyn-1-yl]-4-fluoro-4-piperidinyl]carbonyl]-N-methyl-L-valyl-3-[4-[(2R)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-2-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-1H-indol-5-yl]-2-morpholinyl]-L-alanyl]hexahydro-3-pyridazinecarboxylic acid (3→2)-lactone;3-Pyridazinecarboxylic acid, N1-[N-[[1-[4-(dimethylamino)-4-methyl-1-oxo-2-pentyn-1-yl]-4-fluoro-4-piperidinyl]carbonyl]-N-methyl-L-valyl-3-[4-[(2R)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-2-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-1H-indol-5-yl]-2-morpholinyl]-L-alanyl]hexahydro-, (3→2)-lactone, (3S)…
- CBNumber
- CB113267341
- Molecular Formula
- C55H78FN9O8
- Formula Weight
- 1012.28
- MOL File
- 2641998-63-0.mol
RMC6291 Property
- Density
- 1.25±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
- solubility
- Acetonitrile: Slightly soluble: 0.1-1 mg/ml
DMSO: Sparingly soluble: 1-10 mg/ml - pka
- 13.33±0.40(Predicted)
- form
- Solid
- color
- White to off-white
- InChIKey
- HJNFYLSFWYRSHS-UHFFFAOYSA-N
- SMILES
- C(N1C2=CC=C3N4CCOC(CC(C(N5CCCC(N5)C(OCC(CC(C2=C3)=C1C1C=CC=NC=1C(C)OC)(C)C)=O)=O)NC(=O)C(C(C)C)N(C)C(C1(CCN(CC1)C(=O)C#CC(C)(C)N(C)C)F)=O)C4)C
RMC6291 Chemical Properties,Usage,Production
Uses
Elironrasib is an orally active and covalent inhibitor of KRASG12C(ON). Elironrasib forms a tri-complex within tumor cells between KRASG12C(ON) and cyclophilin A (CypA). Thus, Elironrasib prevents KRASG12C(ON) from signaling via steric blockade of RAS effector binding. Elironrasib inhibits ERK signaling and induced apoptosis in KRASG12C-mutant H358 cells. Elironrasib also inhibits the proliferation of KRASG12C mutant cells with a median IC50 of 0.11 nM[1][2].
in vivo
Elironrasib (200mg/kg, p.o., qd for 60 d) significantly inhibits tumor growth and induce immunological memory in murine tumor models[3].
IC 50
KRAS(G12C)
References
[1] Nichols R J, et al. RMC-6291, a next-generation tri-complex KRASG12C (ON) inhibitor, outperforms KRASG12C (OFF) inhibitors in preclinical models of KRASG12C cancers[J]. Cancer Research, 2022, 82(12_Supplement): 3595-3595.
[2] Schulze CJ, et al. Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS. Science. 2023 Aug 18;381(6659):794-799. DOI:10.1126/science.adg9652
[3] Cristina Blaj, et al. Enhancement of anti-tumor immunity in immunogenic and immune-refractory RAS mutant tumors with tri-complex RAS(ON) inhibitors, revmed, #PB044, 2022
RMC6291 Preparation Products And Raw materials
Raw materials
Preparation Products
RMC6291 Suppliers
- Tel
- 0513-66337626 18051384581
- sales@chemhifuture.com
- Country
- China
- ProdList
- 5929
- Advantage
- 58
- Tel
- 15869524721
- 3525679403@qq.com
- Country
- China
- ProdList
- 4989
- Advantage
- 58
- Tel
- 19231718652
- 278191416@qq.com
- Country
- China
- ProdList
- 482
- Advantage
- 58
- Tel
- +21-18501659228 18501659228
- Fax
- sales@hope-chem.com
- info@hope-chem.com
- Country
- China
- ProdList
- 474
- Advantage
- 55
- Tel
- 0531-0531-88892685 18660160628
- 15069007290@163.com
- Country
- China
- ProdList
- 154
- Advantage
- 58
- Tel
- 19066311943
- 815989315@qq.com
- Country
- China
- ProdList
- 797
- Advantage
- 58
- Tel
- 15727060112
- yutianchun2007@126.com
- Country
- China
- ProdList
- 9814
- Advantage
- 58
- Tel
- 191-19137044811 19137644811
- 3649307081@qq.com
- Country
- China
- ProdList
- 500
- Advantage
- 58
- Tel
- 021-52996696,15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4769
- Advantage
- 55
- Tel
- 021-61350663 13052117465
- Fax
- 021-61350662
- sales@zehanbiopharma.com
- Country
- China
- ProdList
- 984
- Advantage
- 55